Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow-to-Debt Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow-to-Debt Ratio of -0.14x as of December 2025, meaning its operating cash flow of CN¥-26.19 Million could theoretically repay 0% of its total liabilities (CN¥181.12 Million) in one year. See Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 7 annual periods. Also explore 301089 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2025)
Year-by-year debt coverage analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For market capitalisation and broader financial context, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | CN¥-26.19 Million | CN¥181.12 Million | ▼ -129.0% |
| 2024 | 0.50x | CN¥102.67 Million | CN¥205.72 Million | ▲ +336.5% |
| 2023 | 0.11x | CN¥26.95 Million | CN¥235.72 Million | ▼ -80.1% |
| 2022 | 0.58x | CN¥268.85 Million | CN¥466.89 Million | ▲ +193.2% |
| 2021 | 0.20x | CN¥58.19 Million | CN¥296.35 Million | ▼ -25.4% |
| 2020 | 0.26x | CN¥120.00 Million | CN¥455.61 Million | ▲ +8.8% |
| 2019 | 0.24x | CN¥86.38 Million | CN¥356.74 Million | — |